- Home
- XRAY vs OGN Comparison
XRAY vs OGN Comparison
Compare XRAY & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRAY
- OGN
- Stock Information
- Founded
- XRAY 1899
- OGN 1923
- Country
- XRAY United States
- OGN United States
- Employees
- XRAY N/A
- OGN N/A
- Industry
- XRAY Medical/Dental Instruments
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- XRAY Health Care
- OGN Health Care
- Exchange
- XRAY Nasdaq
- OGN Nasdaq
- Market Cap
- XRAY 3.1B
- OGN 4.0B
- IPO Year
- XRAY 1987
- OGN N/A
- Fundamental
- Price
- XRAY $15.91
- OGN $15.57
- Analyst Decision
- XRAY Buy
- OGN Hold
- Analyst Count
- XRAY 13
- OGN 5
- Target Price
- XRAY $24.33
- OGN $20.80
- AVG Volume (30 Days)
- XRAY 2.9M
- OGN 3.5M
- Earning Date
- XRAY 05-01-2025
- OGN 05-01-2025
- Dividend Yield
- XRAY 4.09%
- OGN 7.18%
- EPS Growth
- XRAY N/A
- OGN N/A
- EPS
- XRAY N/A
- OGN 3.33
- Revenue
- XRAY $3,793,000,000.00
- OGN $6,403,000,000.00
- Revenue This Year
- XRAY N/A
- OGN N/A
- Revenue Next Year
- XRAY $2.56
- OGN $1.52
- P/E Ratio
- XRAY N/A
- OGN $4.69
- Revenue Growth
- XRAY N/A
- OGN 2.24
- 52 Week Low
- XRAY $15.47
- OGN $13.87
- 52 Week High
- XRAY $34.28
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- XRAY 30.15
- OGN 55.02
- Support Level
- XRAY $15.84
- OGN $14.13
- Resistance Level
- XRAY $16.41
- OGN $16.18
- Average True Range (ATR)
- XRAY 0.69
- OGN 0.60
- MACD
- XRAY -0.18
- OGN 0.04
- Stochastic Oscillator
- XRAY 11.58
- OGN 78.59
About XRAY DENTSPLY SIRONA Inc.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.